Marc Corbera‐Bellalta

Relapses in Patients With Giant Cell Arteritis

Marco A. Alba, Ana García‐Martínez, Sergio Prieto‐González et al. · Medicine · 2014 · 210 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility

F. David Carmona, Sarah Mackie, Jose‐Ezequiel Martín et al. · The American Journal of Human Genetics · 2015 · 178 citations · Full text

Life Sciences, Genetics, Immunology +17

Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis

Marc Corbera‐Bellalta, Ester Planas‐Rigol, Ester Lozano et al. · Annals of the Rheumatic Diseases · 2015 · 124 citations · Full text

Life Sciences, Immunology, Pathology +17

Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis

Georgina Espígol‐Frigolé, Marc Corbera‐Bellalta, Ester Planas‐Rigol et al. · Annals of the Rheumatic Diseases · 2012 · 104 citations

Life Sciences, Immunology, Pharmacotherapy +17

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

F. David Carmona, Augusto Vaglio, Sarah Mackie et al. · The American Journal of Human Genetics · 2016 · 104 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10